Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Current drug metabolism

• Publication date

  2000-06-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1389200003339234PMID 11467078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fifty years of research onN-acetyl-2-aminofluorene, one of the most versatile compounds in experimental cancer research

  2005cited by this paper
• Prostaglandin H synthase dependent metabolism of diethylstilbestrol by ram seminal vesicle cell cultures

  2005cited by this paper
• Importance of peri-interactions on the stereospecificity of rat hydroxysteroid sulfotransferase STa with 1-arylethanols.

  1999cited by this paper
• Activation of propane 2-nitronate to a genotoxicant in V79-derived cell lines engineered for the expression of rat hepatic sulfotransferases.

  1999cited by this paper
• Characterization of human iodothyronine sulfotransferases.

  1999cited by this paper
• Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems.

  1998cited by this paper
• Mutagenicity of 6-sulfooxymethylbenzo[a]pyrene in Salmonella typhimurium and Chinese hamster V79 cells.

  1998cited by this paper
• Bioactivation of the proximal food mutagen 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) to DNA-binding species by human mammary gland enzymes.

  1998cited by this paper
• Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture.

  1998cited by this paper
• N2-amination of guanine to 2-hydrazinohypoxanthine, a novel in vivo nucleic acid modification produced by the hepatocarcinogen 2-nitropropane.

  1998cited by this paper
• Immunochemical identification of hepatic protein adducts derived from estragole.

  1998cited by this paper
• Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases.

  1998cited by this paper
• 9-Sulfooxymethylanthracene is an ultimate electrophilic and carcinogenic form of 9-hydroxymethylanthracene.

  1998cited by this paper
• Metabolic activation of methyl-hydroxylated derivatives of 7,12-dimethylbenz[a]anthracene by human liver dehydroepiandrosterone-steroid sulfotransferase.

  1998cited by this paper
• Is tamoxifen effective in prevention of breast cancer?

  1998cited by this paper
• Food-derived carcinogens and breast cancer risk.

  1998cited by this paper
• Carcinogenicity of 1-hydroxy-3-methylcholanthrene and its electrophilic sulfate ester 1-sulfooxy-3-methylcholanthrene in Sprague-Dawley rats.

  1998cited by this paper
• Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells.

  1998cited by this paper
• Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts.

  1998cited by this paper
• Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts.

  1998cited by this paper
• Sulfotransferase-mediated genotoxicity of propane 2-nitronate in cultured ovine seminal vesicle cells.

  1998cited by this paper
• Bioactivation of benzylic and allylic alcohols via sulfo-conjugation.

  1998cited by this paper
• Expression of human estrogen sulfotransferase in Salmonella typhimurium: differences between hHST and hEST in the enantioselective activation of 1-hydroxyethylpyrene to a mutagen.

  1998cited by this paper
• Characterization of thyroid hormone sulfotransferases.

  1998cited by this paper
• Arylamine activating sulfotransferase in liver.

  1997cited by this paper
• 7-Sulfooxymethylbenz[a]anthracene is an ultimate electrophilic and carcinogenic form of 7-hydroxymethylbenz[a]anthracene.

  1997cited by this paper
• Oxidation-dependent inactivation of aryl sulfotransferase IV by primary N-hydroxy arylamines during in vitro assays.

  1997cited by this paper
• High level expression and characterization of recombinant human hippocampus phenol sulfotransferase: a novel phenol-sulfating form of phenol sulfotransferase.

  1997cited by this paper
• Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.

  1997cited by this paper
• Studies on the interactions of chiral secondary alcohols with rat hydroxysteroid sulfotransferase STa.

  1997cited by this paper
• Inhibition of sulfotransferase affecting in vivo genotoxicity and DNA adducts induced by safrole in rat liver.

  1997cited by this paper
• Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells.

  1997cited by this paper
• Bioactivation of mutagens via sulfation

  1997cited by this paper
• 7-Sulfooxymethyl-12-methylbenz[a]anthracene is an exceptionally reactive electrophilic mutagen and ultimate carcinogen.

  1997cited by this paper
• Amination of tyrosine in liver cytosol protein of male F344 rats treated with 2-nitropropane, 2-nitrobutane, 3-nitropentane, or acetoxime.

  1997cited by this paper
• 6-sulfooxymethylbenzo[a]pyrene is an ultimate electrophilic and carcinogenic form of the intermediary metabolite 6-hydroxymethylbenzo[a]pyrene.

  1997cited by this paper
• 1-Sulfooxymethylpyrene is an electrophilic mutagen and ultimate carcinogen of 1-methyl- and 1-hydroxymethylpyrene.

  1996cited by this paper
• Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?

  1996cited by this paper
• Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines.

  1996cited by this paper
• Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes.

  1996cited by this paper
• Influence of substrate structure on the catalytic efficiency of hydroxysteroid sulfotransferase STa in the sulfation of alcohols.

  1996cited by this paper
• Dose‐dependent Induction of Mammary Carcinomas in Female Sprague‐Dawley Rats with 2‐Amino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridine

  1996cited by this paper
• Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine(PhIP) at the Chinese hamsters hprt locus.

  1996cited by this paper
• Metabolic activation and DNA binding of food mutagens and other environmental carcinogens in human mammary epithelial cells.

  1996cited by this paper
• Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation.

  1996cited by this paper
• Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients.

  1996cited by this paper
• N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland.

  1996cited by this paper
• Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone.

  1996cited by this paper
• Steroid sulfotransferases.

  1996cited by this paper
• Steroid sulfotransferases.

  1996cited by this paper
• Sulfotransferase-mediated activation of 7,8,9,10-tetrahydro-7-ol, 7,8-dihydrodiol, and 7,8,9,10-tetraol derivatives of benzo[a]pyrene.

  1995cited by this paper
• Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).

  1995cited by this paper
• A correlation of Salmonella mutagenicity with DNA adducts induced by the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

  1995cited by this paper
• Evidence for (+)-cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat.

  1995cited by this paper
• Secondary nitroalkanes: induction of DNA repair in rat hepatocytes, activation by aryl sulfotransferase and hepatocarcinogenicity of 2-nitrobutane and 3-nitropentane in male F344 rats.

  1995cited by this paper
• Metabolism of the genotoxicant 2-nitropropane to a nitric oxide species.

  1995cited by this paper
• Intrinsic mutagenicity and electrophilicity of 1-sulfooxy-3-methylcholanthrene: implications for metabolic activation of the carcinogen 3-methylcholanthrene.

  1995cited by this paper
• Metabolic activation of the N-hydroxy derivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases.

  1995cited by this paper
• Bioactivation of 5-hydroxymethyl-2-furaldehyde to an electrophilic and mutagenic allylic sulfuric acid ester.

  1995cited by this paper
• Human fetal adrenal hydroxysteroid sulphotransferase: cDNA cloning, stable expression in V79 cells and functional characterisation of the expressed enzyme.

  1995cited by this paper
• Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed in Escherichia coli.

  1995cited by this paper
• Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research.

  1995cited by this paper
• Optical resolution of 1-arylethanols with a condensed aromatic ring by lipase from Pseudomonas aeruginosa.

  1995cited by this paper
• Activation of the liver carcinogen 2-nitropropane by aryl sulfotransferase.

  1994cited by this paper
• Activation of benzylic alcohols to mutagens by human hepatic sulphotransferases.

  1994cited by this paper
• Substance-dependent sex differences in the activation of benzylic alcohols to mutagens by hepatic sulfotransferases of the rat.

  1994cited by this paper
• Activation of the Maillard reaction product 5-(hydroxymethyl)furfural to strong mutagens via allylic sulfonation and chlorination.

  1994cited by this paper
• Molecular specificity of aryl sulfotransferase IV (tyrosine-ester sulfotransferase) for xenobiotic substrates and inhibitors.

  1994cited by this paper
• Research in chemical carcinogenesis with Elizabeth Miller--a trail of discovery with our associates.

  1994cited by this paper
• Activation of 2‐Hydroxyamino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridne by cDNA‐expressed Human and Rat Arylsulfotransferases

  1994cited by this paper
• Metabolic activation of N-hydroxylated metabolites of carcinogenic and mutagenic arylamines and arylamides by esterification.

  1994cited by this paper
• Major hydroxysteroid sulfotransferase STa in rat liver cytosol may consist of two microheterogeneous subunits.

  1994cited by this paper
• Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites.

  1994cited by this paper
• Sulfation pharmacogenetics in humans.

  1994cited by this paper
• 5-Sulfooxymethylfurfural as a possible ultimate mutagenic and carcinogenic metabolite of the Maillard reaction product, 5-hydroxymethylfurfural.

  1994cited by this paper
• The same enzymes catalyze sulfation of minoxidil, minoxidil analogs and catecholamines.

  1994cited by this paper
• alpha-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes.

  1994cited by this paper
• Sulfonation in chemical carcinogenesis--history and present status.

  1994cited by this paper
• Steroid sulfation by expressed human cytosolic sulfotransferases.

  1994cited by this paper
• Sulfation of carcinogenic aromatic hydroxylamines and hydroxamic acids by rat and human sulfotransferases: substrate specificity, developmental aspects and sex differences.

  1994cited by this paper
• Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalysing covalent binding of carcinogenic polycyclic arylmethanols to DNA.

  1994cited by this paper
• Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclin amines in cooked foods

  1994cited by this paper
• Interindividual variability of the human hepatic sulphotransferases.

  1994cited by this paper
• Sulfonation in Chemical Carcinogenesis

  1994cited by this paper
• Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil.

  1993cited by this paper
• The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

  1993cited by this paper
• Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats.

  1993cited by this paper
• Sulfotransferase-mediated mutagenicity of 1-hydroxymethylpyrene and 4H-cyclopenta[def]chrysen-4-ol and its enhancement by chloride anions.

  1993cited by this paper
• Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene.

  1993cited by this paper
• The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein.

  1993cited by this paper
• Naphthaldehydes as reversible inhibitors of rat hepatic aryl sulfotransferase IV (tyrosine-ester sulfotransferase).

  1993cited by this paper
• Aryl sulfotransferase-IV-catalyzed sulfation of aryl oximes: steric and substituent effects.

  1993cited by this paper
• Sulfotransferase-mediated activation of 4-hydroxy- and 3,4-dihydroxy-3,4-dihydrocyclopenta[c,d]pyrene, major metabolites of cyclopenta[c,d]pyrene.

  1993cited by this paper
• Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.

  1993cited by this paper
• Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

  1993cited by this paper
• 8-Aminoguanine: a base modification produced in rat liver nucleic acids by the hepatocarcinogen 2-nitropropane.

  1993cited by this paper
• Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV.

  1992cited by this paper
• Interactions of a primary N-hydroxy arylamine with rat hepatic aryl sulfotransferase IV.

  1992cited by this paper
• Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal.

  1992cited by this paper
• Sulfotransferase-mediated DNA binding of N-hydroxyarylamines(amide) in liver cytosols from human and experimental animals.

  1992cited by this paper

• Impacts of 119 missense variants at functionally important sites of drug-metabolizing human cytosolic sulfotransferase SULT1A1: An in silico study

  2022cites this paper
• Metabolic Activation of Gemfibrozil Mediated by Cytochrome P450 Enzymes and Sulfotransferases.

  2022cites this paper
• Non-innocuous Consequences of Metabolic Oxidation of Alkyls on Arenes.

  2022cites this paper
• Recent developments in predicting CYP-independent metabolism

  2021cites this paper
• Genetic polymorphism of Arg213His variant in the SULT1A1 gene is associated with reduced susceptibility to lung cancer in North Indian population

  2021cites this paper
• DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol.

  2021cites this paper
• Developmental Expression of SULT1C4 Transcript Variants in Human Liver: Implications for Discordance Between SULT1C4 mRNA and Protein Levels.

  2020cites this paper
• Structural and Dynamic Characterizations Highlight the Deleterious Role of SULT1A1 R213H Polymorphism in Substrate Binding

  2019cites this paper
• The Structural Basis for the Production of Cancer and Detoxification by Oxidized Metabolites of Mesoanthracenic Methylated and Non-Methylated Polynuclear Hydrocarbons: a Paradigm Shift

  2019cites this paper
• Characterization Of Cytosolic Sulfotransferase Expression And Regulation In Human Liver And Intestine

  2019influential citation
• In vitro metabolism of the synthetic cannabinoids PX-1, PX-2, PX-3 and a comparison of their clearance rates in human liver microsomes

  2019cites this paper
• Structural Dissection and Optimization of a Cation–π–π Stacking System in Human Pregnancy-Related Serine Protease–Peptide Complex

  2019cites this paper
• 14.03 – Renal Xenobiotic Metabolism☆

  2018cites this paper
• Drug metabolism and metabolite safety assessment in drug discovery and development

  2018cites this paper
• Cytochrome P450 and Oxidative Stress in the Liver

  2017cites this paper
• Diclofenac in Arabidopsis cells: Rapid formation of conjugates.

  2017cites this paper
• The effects of CYP1A inhibition on alkyl-phenanthrene metabolism and embryotoxicity in marine medaka (Oryzias melastigma)

  2016cites this paper
• Structure, function and carcinogenicity of metabolites of methylated and non-methylated polycyclic aromatic hydrocarbons: a comprehensive review

  2016cites this paper
• Drug Metabolizing Enzymes in Type II Diabetes and their Pharmacogenetics During Therapy of Anti-Diabetes Drugs.

  2015cites this paper
• RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.

  2015cites this paper
• Investigation of the bi-substrate kinetics of a recombinant human glycine N-acyltransferase with a known non-synonymous single nucleotide polymorphism (N156S)

  2015cites this paper
• Hydrastine Pharmacokinetics and Metabolism after a Single Oral Dose of Goldenseal (Hydrastis canadensis) to Humans

  2015cites this paper
• Bioactive heterocycles containing endocyclic N-hydroxy groups.

  2015cites this paper
• Detoxification function of the Arabidopsis sulphotransferase AtSOT12 by sulphonation of xenobiotics.

  2015cites this paper
• Predictive biomarkers in precision medicine and drug development against lung cancer

  2015cites this paper
• Chapter 24 – Biotransformation Reactions and their Enzymes

  2015cites this paper
• 3. Metabolism: Principle, Methods, and Applications

  2015cites this paper
• Danning tablets attenuates α-naphthylisothiocyanate-induced cholestasis by modulating the expression of transporters and metabolic enzymes

  2014cites this paper
• The toxicity of alkyl-chrysenes and benz[a]anthracenes to embryonic fish

  2014cites this paper
• Major Human Conjugative Drug‐Metabolizing Enzymes

  2014cites this paper
• Biotransformation of endocrine disrupting compounds by selected phase I and phase II enzymes--formation of estrogenic and chemically reactive metabolites by cytochromes P450 and sulfotransferases.

  2014cites this paper
• Heterologous microarray analysis of transcriptome alterations in Mus spretus mice living in an industrial settlement.

  2014cites this paper
• Regulation of the cytosolic sulfotransferases by nuclear receptors

  2013influential citation
• External Balance of Electrolytes and Acids and Alkali

  2013cites this paper
• Metabolic profiling of TRPV1 antagonists of the benzothiazole amide series: implications for in vitro genotoxicity assessment

  2013cites this paper
• Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity

  2013cites this paper
• Antitumor Drugs and Nitrenium Ions

  2012cites this paper
• Roles of human sulfotransferases in genotoxicity of carcinogens using genetically engineered umu test strains

  2012cites this paper
• Bioactivation by Phase‐II‐Enzyme‐Catalyzed Conjugation of Xenobiotics

  2012cites this paper
• Sulfotransferase 1A1 Arg(213)His polymorphism and prostate cancer risk.

  2011cites this paper
• Cloning and characterization of cytosolic sulfotransferases from channel catfish liver

  2011cites this paper
• Identification of phase II in vivo metabolites of alkyl-anthracenes in rainbow trout (Oncorhynchus mykiss).

  2011cites this paper
• Common Biotransformation Reactions

  2011cites this paper
• Sulfotransferase 1A1 Arg213His polymorphism and prostate cancer risk

  2011cites this paper
• Characterisation of the SULT1A1 polymorphism in a South African Tswana population group

  2010cites this paper
• The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.

  2010cites this paper
• Effects of the loss of multidrug resistance associated protein 1 on steroid homeostasis, dendritic cell function and compensatory mechanisms

  2010cites this paper
• Early Screening for ADMET Properties

  2010cites this paper
• N‐Arylhydroxylamines and Chemical Carcinogenicity

  2010cites this paper
• Renal Xenobiotic Metabolism

  2010cites this paper
• A stress-inducible sulphotransferase sulphonates salicylic acid and confers pathogen resistance in Arabidopsis.

  2010cites this paper
• 4.18 – Sulfotransferases

  2010cites this paper
• Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes.

  2010cites this paper
• Estrogen Sulfotransferases in Breast and Endometrial Cancers

  2009cites this paper
• Regulation of Sulfotransferase and UDP-Glucuronosyltransferase Gene Expression by the PPARs

  2009cites this paper
• Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study

  2009cites this paper
• Structure, function and polymorphism of human cytosolic sulfotransferases.

  2008cites this paper
• PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression

  2008cites this paper
• Characterization and ontogenic study of novel steroid-sulfating SULT3 sulfotransferases from zebrafish.

  2008cites this paper
• In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery.

  2008cites this paper
• Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level.

  2008cites this paper
• E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2

  2008cites this paper
• The Biochemistry of Drug Metabolism – An Introduction

  2008cites this paper
• Biotransformation Reactions and Their Enzymes

  2008cites this paper
• CHAPTER 10 – External Balance of Electrolytes and Acids and Alkali

  2008cites this paper
• Principles of Drug Metabolism 2: Hydrolysis and Conjugation Reactions

  2007cites this paper
• Cigarette smoke toxicants as substrates and inhibitors for human cytosolic SULTs.

  2007cites this paper
• Influence of structural and functional modifications of selected genotoxic carcinogens on metabolism and mutagenicity – a review

  2007cites this paper
• Phase II Biotransformation Reactions-Sulfotransferase

  2007cites this paper
• THE IN VITRO METABOLISM OF THREE ANTICANCER DRUGS

  2007cites this paper
• Natural polyphenol disposition via coupled metabolic pathways

  2007cites this paper
• Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting

  2007cites this paper
• Impact of polymorphism in sulfotransferase gene on the risk of lung cancer.

  2006cites this paper
• Inhibition of sulfotransferases by xenobiotics.

  2006cites this paper
• Pentachlorophenol inhibits micronuclei induction by 2-acetylaminofluorene but not by thioacetamide.

  2006cites this paper
• In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives.

  2006cites this paper
• Identification of sulfation sites of metabolites and prediction of the compounds’ biological effects

  2006cites this paper
• Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes.

  2006cites this paper
• Metabolism: A Bottleneck in In Vitro Toxicological Test Development

  2006cites this paper
• Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions.

  2005cites this paper
• Human SULT1A SULTs

  2005cites this paper
• A comprehensive listing of bioactivation pathways of organic functional groups.

  2005cites this paper
• Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1

  2005cites this paper
• Differential Cell Type-Specific Transcriptional Regulation of the CYP1A1 Gene

  2005cites this paper
• The Structure of Human SULT1A1 Crystallized with Estradiol

  2005cites this paper
• Induction of phase I, II and III drug metabolism/transport by xenobiotics

  2005influential citation
• Estrogen Sulfotransferase in Breast Cancer

  2005cites this paper
• Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole.

  2005cites this paper
• Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue.

  2005cites this paper
• Effects of culture with TNF-alpha, TGF-beta and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines.

  2004cites this paper
• Effects of culture with TNF-α, TGF-β and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines

  2004cites this paper
• FORMATION OF BENZYLIC ALCOHOLS AND MESO-ALDEHYDES BY ONE-ELECTRON OXIDATION OF DMBA, A MODEL FOR THE FIRST METABOLIC STEP IN METHYLATED CARCINOGENIC HYDROCARBON ACTIVATION

  2004cites this paper
• Differential gene expression in gram-negative and gram-positive sepsis.

  2004cites this paper
• Active Site Mutations and Substrate Inhibition in Human Sulfotransferase 1A1 and 1A3*

  2004cites this paper
• In Vitro Drug Metabolite Profiling Using Hepatic S9 and Human Liver Microsomes

  2004cites this paper
• Mass spectrometric analysis of 7-sulfoxymethyl-12-methylbenz[a]anthracene and related electrophilic polycyclic aromatic hydrocarbon metabolites.

  2004cites this paper
• A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking.

  2003cites this paper
• The metabolism of formyl-substituted benzanthracenes to hydroxymethyl metabolites in rat liver in vitro and in vivo.

  2003cites this paper
• 4‐Hydroxytamoxifen sulfation metabolism

  2002cites this paper
• Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate

  2002cites this paper